How to Buy Bausch & Lomb Stock
Bausch & Lomb Corp
Bausch & Lomb is a medical company located in British Columbia, Canada, which is part of the Healthcare sector, and is traded under the ticker BLCO on the NYSE exchange.
Bausch & Lomb stock last closed at $16.18, up 1.7% from the previous day, and has increased 40.7% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.47 percentage points. Bausch & Lomb stock is currently +47.22% from its 52-week low of $10.99, and -14.46% from its 52-week high of $18.92.
As of May 8, 2026, there are 356.54M BLCO shares outstanding. The market capitalization of BLCO is $5.77B. In the last 24 hours, 539,000 BLCO shares were traded.
How to Buy Bausch & Lomb Stock
Wondering how to invest in Bausch & Lomb stock? Here's how.
- Choose where to buy Bausch & Lomb stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you determine where to buy Bausch & Lomb stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your investment account: Pick your payment method and add your info.
- Evaluate Bausch & Lomb stock: The Bausch & Lomb ticker symbol is BLCO. Is Bausch & Lomb stock a good investment? Should you buy shares of BLCO? How do BLCO's underlying business fundamentals look? Do top analysts think Bausch & Lomb is a good buy? Why has BLCO's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if BLCO is a good stock to buy).
- Make your BLCO purchase: Decide if you will purchase BLCO shares at the current market price or use a limit order to purchase BLCO stock at a specific price.
- Track your BLCO position: Create a watchlist to get live updates on your new investment in Bausch & Lomb shares.
Step 1: Choose where to buy Bausch & Lomb stock
You need a brokerage account to access the NYSE market and buy BLCO stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Energy, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen your brokerage, you need to fill out some personal info so you are able to invest in BLCO today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create your new trading account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've filled out your info on stock market apps, your next step is to transfer the money for your investment:
Watch the tutorial below if you need help depositing funds into your investment account.
Step 4: Evaluate Bausch & Lomb stock
Once you have selected the best place to buy Bausch & Lomb stock, it's critical to evaluate their stock before you buy, so you actually wrap your head around the risk and opportunity.
Bausch & Lomb Numbers
Fundamentals of Bausch & Lomb
WallStreetZen was created to help part-time investors do better fundamental analysis quickly.
You can view all of the due diligence checks on BLCO's stock page.
Is BLCO stock undervalued or overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge BLCO's fair value.
Using relative valuations metrics:
- BLCO could be undervalued based on its P/B ratio of 0.9x, relative to Medical Instruments & Supplies industry P/B ratio of 3.3x
You can do additional valuation analysis on BLCO's stock here.
BLCO Financial Health Summary
Signs that BLCO is financially healthy:
- There are more short-term assets than short-term liabilities on the BLCO balance sheet.
- BLCO profit margin has gone up from -7.5% to -4.2% in the past year.
Signs that BLCO is not financially healthy:
- There are more long-term liabilities than short-term assets on the BLCO balance sheet.
- BLCO has a relatively high debt to equity ratio of 1.15.
- BLCO earnings of $215.00M is not enough to cover its interest payments.
- BLCO's operating cash flow of $340.00M allows it to safely service it's debt of $5.07B.
Do analysts think it's a good time to buy Bausch & Lomb stock
Out of 8 Wall Street analysts who give ratings on BLCO, the consensus analyst rating on Bausch & Lomb is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Latest BLCO Analyst Ratings
Larry Biegelsen, a top 23% analyst from Wells Fargo maintains BLCO with a hold rating and raises their BLCO price target from $17.00 to $18.00, on Feb 19, 2026.
Patrick Wood, a top 43% analyst from Morgan Stanley upgrades BLCO to a strong buy rating and raises their BLCO price target from $14.00 to $21.00, on Dec 2, 2025.
Douglas Miehm, a bottom 13% analyst from RBC Capital maintains BLCO with a buy rating and raises their BLCO price target from $17.00 to $19.00, on Nov 14, 2025.
You can dive deeper into what analysts are saying on the Bausch & Lomb stock forecast page.
BLCO Technical Indicators
BLCO Performance Numbers
Last year, BLCO revenue was $5.21B. Over the last 4 year, BLCO's revenue has gone up by 8.39% per year. This was slower than the Medical Instruments & Supplies industry average of 9.93%.
You can research BLCO's earnings and revenue performance here.
Are BLCO insiders buying or selling the stock?
Over the last year, executives and large shareholders at BLCO have sold more shares than they have bought.
Luc Bonnefoy, President Surgical of BLCO, was the latest BLCO insider to sell. They sold $191,520.00 worth of BLCO stock on May 5, 2026.
Research more about who owns BLCO shares here.
Can I rely on BLCO as an income stream?
No, Bausch & Lomb doesn't provide an income stream by paying out dividends.
BLCO Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your BLCO purchase
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally sufficient. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact price limit, place a limit order.
Hit the Open button and eToro will place your order.
If you need more help investing in stocks on eToro, watch the how to video below:
Step 6: Track your BLCO position
Now that you own some shares in BLCO, you'll want to stay up-to-date on your new investment.
Add BLCO to a watchlist to keep track of your BLCO stock.
BLCO Feed
How to Buy Stock in Bausch & Lomb
To reiterate, here are the 6 steps to buy stock in Bausch & Lomb:
- Choose where to buy Bausch & Lomb stock
- Create a brokerage account
- Put funds into your investment account
- Evaluate Bausch & Lomb stock
- Make your BLCO purchase
- Track your BLCO position
If you need a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to monitor your investment in Bausch & Lomb, hit the button below to create your watchlist.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.